Panavance Announces New Discovery that Misetionamide Directly Inhibits Oncogenic Transcription Factor c-MYC
(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...
c-span17h
Sen. Minority Leader Mitch McConnell on missing and exploited children
This text was compiled from uncorrected Closed Captioning. MyC-SPAN users can download four Congressional hearings and ...
c-span19h
CBS Congressional Correspondent Scott MacFarlane on covering Washington politics as a journalist
MyC-SPAN users can download four Congressional hearings and proceedings under four hours for free each month.
manilatimes7h
RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development
With the support of the RiDYMO® platform, we are able to comprehensively explore various potential targets in drug ...
EurekAlert!22h
How marine worms regenerate lost body parts
Many living organisms are able to regenerate damaged or lost tissue, but why some are particularly good at this and others ...
Yahoo Finance2h
Drone maker AeroVironment seeks lift from $4.1 billion deal for BlueHalo
(Reuters) -AeroVironment will buy space and defense engineering company BlueHalo in an all-stock deal valued at about $4.1 ...